Search This Blog

Monday, August 12, 2019

NextCure EPS misses by $0.14, misses on revenue

NextCure (NASDAQ:NXTC): Q2 GAAP EPS of -$0.61 misses by $0.14.
Revenue of $1.4M misses by $1.21M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)